|
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||
How to Use the PocketGuide | Design of the PocketGuide | Medical Criteria for Use of Contraceptive Methods | World Health Organization Classification System | WHO Classification System | Harmonizing the PocketGuide with International Medical Criteria |
|||||||||||||||||||||||||||
| The PocketGuide for Family Planning Service Providers
was designed to provide clinicians with easily accessible, clinically-oriented information
for use in family planning service provision. It was intended to be used by those who need
immediate answers to questions about a client's condition or a contraceptive method but
cannot wait for an answer until getting to a library or other reference material. The PocketGuide has been used in this way but clinicians throughout the world have found additional uses as well. For example, the PocketGuide is used in many inservice and preservice training programs as a reference manual. To make this valuable information available to a wider audience, we have created this online version. It contains all of the same information as the print version; the difference is the way in which users can access the information. The information in the PocketGuide is organized according to two types of clinical situations:
In addition, the user is provided with supplemental information on counseling, client assessment and client instructions which s/he will need when working in the clinic or office. Finally, essential information has been included for reference when providing services which involve:
More information exists on family planning methods, especially combined oral contraceptives (COCs) and IUDs, than for almost any medical subject. Unfortunately, this information is not always easily accessible, nor is it written and arranged in a "user friendly" manner. To correct these problems, the information in the PocketGuide is limited to the essentials. A detailed table of contents makes it easy to find what is needed for a given clinical situation while links guide the user to additional information. A contraindication is a condition or a disease that makes a drug or treatment unsafe or inadvisable for a client. In the past, to protect the client from contraceptive complications, lists of contraindications had been developed for each contraceptive method. Although such lists were produced with the best interest of the client in mind, potentially serious, but often rare complications were overemphasized. In addition, while contraindications change over time, the lists tend to become permanent. (The same is true to a certain extent for lists of indications.) Moreover, what may be an appropriate contraindication in one country may not be appropriate when applied to a setting that has different reproductive health characteristics. Finally, in many countries, new information is slow in arriving and the contraindication list remains the standard for many years. In the PocketGuide, we have chosen to replace contraindications with conditions requiring precaution. Making this change, however, does not solve the problem of "lists" entirely. Therefore, in addition to listing the indications and those conditions requiring precaution, a brief statement is included explaining the rationale for categorizing the condition as such. During 1994-1995, a series of working group meetings was held at the World Health Organization (WHO) to review medical criteria for initiation and continuation of all commonly available methods of contraception including voluntary sterilization (VS). The members of these scientific working groups developed a classification system and applied it to all methods of contraception (a separate system was developed for VS procedures-see the Voluntary Sterilization chapter). In the resulting classification system, the suitability of different contraceptive methods is determined by weighing the health risks and benefits relative to specific "conditions." (A condition is defined to include both a woman's biologic characteristics such as age or reproductive history and any known, pre-existing medical problem(s) such as diabetes or hypertension.) The presence of a specific condition affecting eligibility for using a contraceptive method falls into one of four categories:
Assessing Unexplained Vaginal Bleeding Serious pathologic problems (tumors and cancer) are uncommon in women of reproductive age, especially those younger than age 35. For example, unexplained vaginal bleeding in women of this age group is most often due to a pregnancy-related problem (e.g., spontaneous or incomplete abortion or a tubal pregnancy) or a functional disorder such as anovulation. Therefore, only women with unexplained vaginal bleeding that the service provider strongly feels could be caused by a serious problem need to be evaluated before starting a contraceptive method. Women with irregular menstrual bleeding patterns, which are not suspected of being serious, can use any contraceptive method without restriction (WHO Class 1). Special Note on Combined Injectable Contraceptives (CICs) With the second edition of the PocketGuide, we have included CICs (Cyclofem and Mesigyna) for the first time. Although CICs, which contain an estrogen and a progestin, are a relatively new contraceptive method, there is little epidemiologic data on their long-term effects. There is, however, no reason to believe that clients will have more problems with CICs than with COCs-only different and perhaps less serious problems. For example, with CICs, unlike COCs, estrogen is only available during the first 8-11 days following an injection and the levels more closely mimic those during the normal menstrual cycle. As a consequence, cycle control is not quite as good (more breakthrough spotting and bleeding days and amenorrhea) as compared with COCs (see Client Assessment Chapter: Women with Acceptable Bleeding Patterns). However, the more physiologic estrogen dose in CICs has been found to cause less change in blood pressure, blood clotting, lipid metabolism and liver function. On the other hand, while COCs can be stopped immediately, the effect of CICs continues for some time after the last injection.
Throughout the PocketGuide, every effort has been made to harmonize the existing information in order to provide clear guidance to the service provider on the provision of family planning services and management of side effects and other problems. By providing updated knowledge and consistency among different sources of information, it is hoped that:
The PocketGuide complements the WHO classification system. For example, like the WHO system, the PocketGuide includes a brief rationale for why a particular condition is assigned to one of the four categories. (For the reader's convenience, the WHO classification for each condition is included throughout the PocketGuide.) The rationales included in this PocketGuide are adapted not only from those presented in the most recent WHO document but also from those provided in the manual, Recommendations for Updating Selected Practices in Contraceptive Use (Volume 1), produced by the USAID Technical Guidance Working Group (November 1994), and selected references from the international literature on contraceptive technology. |
|
| Home | Family Planning |
Maternal & Neonatal
Health | Cervical
Cancer | Related
Health Topics | |
||
|
Website design copyright © 1995-2003 by JHPIEGO Corporation. All rights reserved. Last Updated: 09 Jul 2003 |
||
|
URL: http://www.reproline.jhu.edu/ |